Effect of PF-00734200 in Subjects With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

PF-00734200 30 mg QD

30 mg QD

DRUG

PF-00734200 20 mg QD

20 mg QD

DRUG

Placebo

Placebo

Trial Locations (79)

13210

Pfizer Investigational Site, Syracuse

20745

Pfizer Investigational Site, Oxon Hill

21204

Pfizer Investigational Site, Baltimore

23225

Pfizer Investigational Site, Richmond

23454

Pfizer Investigational Site, Virginia Beach

23455

Pfizer Investigational Site, Virginia Beach

23803

Pfizer Investigational Site, Ettrick

27103

Pfizer Investigational Site, Winston-Salem

29501

Pfizer Investigational Site, Florence

29801

Pfizer Investigational Site, Aiken

30094

Pfizer Investigational Site, Conyers

32205

Pfizer Investigational Site, Jacksonville

32435

Pfizer Investigational Site, DeFuniak Springs

33143

Pfizer Investigational Site, Miami

33156

Pfizer Investigational Site, Pinecrest

33169

Pfizer Investigational Site, Miami

33702

Pfizer Investigational Site, St. Petersburg

34471

Pfizer Investigational Site, Ocala

34652

Pfizer Investigational Site, New Port Richey

35205

Pfizer Investigational Site, Birmingham

37660

Pfizer Investigational Site, Kingsport

39209

Pfizer Investigational Site, Jackson

39466

Pfizer Investigational Site, Picayune

40504

Pfizer Investigational Site, Lexington

42431

Pfizer Investigational Site, Madisonville

43302

Pfizer Investigational Site, Marion

46260

Pfizer Investigational Site, Indianapolis

48098

Pfizer Investigational Site, Troy

48106

Pfizer Investigational Site, Ann Arbor

48187

Pfizer Investigational Site, Canton

48706

Pfizer Investigational Site, Bay City

53142

Pfizer Investigational Site, Kenosha

63117

Pfizer Investigational Site, St Louis

63141

Pfizer Investigational Site, St Louis

63376

Pfizer Investigational Site, City of Saint Peters

67203

Pfizer Investigational Site, Wichita

75230

Pfizer Investigational Site, Dallas

75235

Pfizer Investigational Site, Dallas

76054

Pfizer Investigational Site, Hurst

77023

Pfizer Investigational Site, Houston

77081

Pfizer Investigational Site, Houston

77584

Pfizer Investigational Site, Pearland

78229

Pfizer Investigational Site, San Antonio

79761

Pfizer Investigational Site, Odessa

79935

Pfizer Investigational Site, El Paso

83404

Pfizer Investigational Site, Idaho Falls

84107

Pfizer Investigational Site, Salt Lake City

85051

Pfizer Investigational Site, Phoenix

85225

Pfizer Investigational Site, Chandler

85340

Pfizer Investigational Site, Litchfield Park

87106

Pfizer Investigational Site, Albuquerque

89128

Pfizer Investigational Site, Las Vegas

90057

Pfizer Investigational Site, Los Angeles

90701

Pfizer Investigational Site, Artesia

90703

Pfizer Investigational Site, Cerritos

91607

Pfizer Investigational Site, Valley Village

91790

Pfizer Investigational Site, West Covina

91950

Pfizer Investigational Site, National City

92648

Pfizer Investigational Site, Huntington Beach

93720

Pfizer Investigational Site, Fresno

94904

Pfizer Investigational Site, Greenbrea

95661

Pfizer Investigational Site, Roseville

97401

Pfizer Investigational Site, Eugene

99208

Pfizer Investigational Site, Spokane

04074

Pfizer Investigational Site, Scarborough

07202

Pfizer Investigational Site, Elizabeth

08611

Pfizer Investigational Site, Trenton

02864

Pfizer Investigational Site, Cumberland

05201-5018

Pfizer Investigational Site, Bennington

V3K 3P4

Pfizer Investigational Site, Coquitlam

M9W 4L6

Pfizer Investigational Site, Toronto

H7T 2P5

Pfizer Investigational Site, Laval

H9R 4S3

Pfizer Investigational Site, Pointe-Claire

G1V 4M6

Pfizer Investigational Site, Québec

00909-1711

Pfizer Investigational Site, San Juan

110-744

Pfizer Investigational Site, Seoul

120-752

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

136-705

Pfizer Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00618007 - Effect of PF-00734200 in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter